| Pharmaceutical active ingredients: |
| Insulin Isophane Human recombinant |
| Available forms, composition and doses of HumaJect M5: |
| Injectable; Injection; Insulin Isophane Human recombinant |
| HumaJect M5 medical category: |
| Human:Insulin preparations |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| A10AB01 - Insulin (Human)A10AC01 - Insulin (Human)A10AD01 - Insulin (Human)A10AE01 - Insulin (Human)A10AF01 - Insulin (Human) |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Eli Lilly |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Mixtard Human 70 / 30 | Insulin Isophane Human Injection; Insulin Neutral Injection Human | Novo Nordisk; Abbott; Bayer Schering Pharma |
| HumaJect I | Insulin Isophane Human recombinant | Eli Lilly |
| HumaJect M1 | Insulin Isophane Human recombinant | Eli Lilly |
| HumaJect M2 | Insulin Isophane Human recombinant | Eli Lilly |
| HumaJect M4 | Insulin Isophane Human recombinant | Eli Lilly |
| Humulin I | Insulin Isophane Human recombinant | Eli Lilly |
| Humulin I Pen | Insulin Isophane Human recombinant | Eli Lilly |
| Insulatard | Insulin Isophane Human recombinant | Novo Nordisk; DKSH; GlaxoSmithKline; Pentafarma |
| Insulatard InnoLet | Insulin Isophane Human recombinant | Novo Nordisk |
| Insulatard Novolet | Insulin Isophane Human recombinant | Novo Nordisk |